封面
市場調查報告書
商品編碼
1259847

煙?胺腺嘌呤二核?酸的全球市場 - 市場佔有率,規模,趨勢,產業分析:各等級,各用途,各地區,市場區隔預測(2023年~2032年)

Nicotinamide Adenine Dinucleotide Market Share, Size, Trends, Industry Analysis Report, By Grade (Food Grade, Pharmaceutical Grade, and Others); By Application; By Region; Segment Forecast, 2023- 2032

出版日期: | 出版商: Polaris Market Research | 英文 118 Pages | 商品交期: 最快1-2個工作天內

價格

全球煙?胺腺嘌呤二核?酸的市場規模到2032年前將達到17億2,211萬美元。

本報告提供全球煙?胺腺嘌呤二核?酸市場相關調查分析,提供市場動態,COVID-19影響,各市場區隔的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 簡介

第2章 摘要整理

第3章 調查手法

第4章 全球煙?胺腺嘌呤二核?酸市場考察

  • 產業的概述
  • 市場動態
    • 促進因素和機會
    • 阻礙因素與課題
  • 波特的五力分析
  • 大環境分析
  • 產業趨勢
  • 價值鏈分析
  • COVID-19影響分析

第5章 全球煙?胺腺嘌呤二核?酸市場:各等級

  • 主要調查結果
  • 簡介
    • 全球煙?胺腺嘌呤二核?酸市場:各等級(2019年~2032年)
  • 食品等級
  • 醫藥品等級
  • 其他

第6章 全球煙?胺腺嘌呤二核?酸市場:各用途

  • 主要調查結果
  • 簡介
    • 全球煙?胺腺嘌呤二核?酸市場:各用途(2019年~2032年)
  • 營養補充品
  • 醫藥品
  • 抗老化產品
  • 其他

第7章 全球煙?胺腺嘌呤二核?酸市場:各地區

  • 主要調查結果
  • 簡介
    • 煙?胺腺嘌呤二核?酸市場評估:各地區(2019年~2032年)
  • 北美
    • 各用途
    • 各等級
    • 美國
    • 加拿大
  • 歐洲
    • 各用途
    • 各等級
    • 英國
    • 法國
    • 德國
    • 義大利
    • 西班牙
    • 荷蘭
    • 俄羅斯
  • 亞太地區
    • 各用途
    • 各等級
    • 中國
    • 印度
    • 馬來西亞
    • 日本
    • 印尼
    • 韓國
  • 中東·非洲
    • 各用途
    • 各等級
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 南非
  • 南美
    • 各用途
    • 各等級
    • 墨西哥
    • 巴西
    • 阿根廷

第8章 競爭情形

  • 擴張和收購的分析
    • 擴張
    • 收購
  • 夥伴關係/合作/協定/展示會

第9章 企業簡介

  • Bontac Bio-engineering
  • Jubilant Life Sciences
  • Koninklijke DSM
  • Lasons India
  • Resonance Specialties
  • TCI Chemcials
  • Vertellus Holdings
  • Novo Nordisk
  • Catalent
  • Lonza Group
  • Zhejiang Lanbo Biotechnology
  • Otto Chemie
  • Himedia Laboratories
  • NutriScience Innovations
Product Code: PM3098

The global nicotinamide adenine dinucleotide market size is expected to reach USD 1,722.11 million by 2032, according to a new study by Polaris Market Research. The report "Nicotinamide Adenine Dinucleotide Market Share, Size, Trends, Industry Analysis Report, By Grade (Food Grade, Pharmaceutical Grade, and Others); By Application; By Region; Segment Forecast, 2023-2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Increasing product penetration as a key supplement for a variety of food ingredients because of the NAD's antioxidant properties coupled with the surge in consumer awareness regarding the health benefits of the product and continuously growing healthcare spending capacity of people across both developed and developing countries are key factors expected to boost the market growth. Moreover, the increasing focus of major market players on developing more advanced and innovative solutions to tackle various issues associated with human health through heavily investing in R&D activities is also creating huge growth opportunities in the market.

NAD+ has been studied extensively across the globe over the last few decades and continues to receive current research attention as several new roles and functions of this cofactor have significantly emerged in the regulation of protein modifications that could help regulate cellular metabolism and a wide range of cellular events. Recent studies have also shown that NAD+ levels can profoundly eliminate or reduce cell damage in catabolic tissue, including the brain. Therefore, the promotion of intracellular NAD+ anabolism shows promising market growth.

Moreover, the NAD+ concentration increases under various conditions associated with reduced energy loads, including glucose deprivation, fasting, caloric restriction, and exercise. Apart from this, these levels are highly elevated under conditions of increased life span or health span, representing a major contributor to aging. Thus, supplementation with the product and its precursors might define a potential therapeutic strategy to mediate protection against the accumulation of inflammation and highly volatile ROS during aging.

Nicotinamide Adenine Dinucleotide Market Report Highlights:

Food grade segment accounted for over considerable global market share in 2022, which is mainly accelerated by its growing adoption as a substrate across various biological processes including DNA repair

Dietary supplements segment dominated the global market in 2022, on account of the widespread adoption of product as an alternative for vitamins and having the ability to help in living longer and healthier lives

Asia Pacific region is expected to witness highest growth rate throughout the forecast period, owing to increasing consumer proliferation for improving immunization and high product adoption across the pharma sector

The global key market players include Jubilant Life Sciences, TCI Chemicals, Vertellus Holdings, Zhenjiang Lanbo Biotechnology, Himedia Laboratories, and Catalent.

Polaris Market Research has segmented the nicotinamide adenine dinucleotide market report based on grade, application, and region:

Nicotinamide Adenine Dinucleotide, Grade Outlook (Revenue - USD Million, 2019 - 2032)

Food Grade

Pharmaceutical Grade

Others

Nicotinamide Adenine Dinucleotide, Application Outlook (Revenue - USD Million, 2019 - 2032)

Dietary Supplements

Pharmaceuticals

Anti-aging Products

Others

  • Nicotinamide Adenine Dinucleotide, Regional Outlook (Revenue - USD Million, 2019 - 2032)

North America

U.S.

Canada

Europe

Germany

UK

France

Italy

Spain

Russia

Netherlands

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Latin America

Argentina

Brazil

Mexico

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Nicotinamide Adenine Dinucleotide Market Insights

  • 4.1. Nicotinamide Adenine Dinucleotide Market - Industry Snapshot
  • 4.2. Nicotinamide Adenine Dinucleotide Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Growing number of product applications in biochemistry
      • 4.2.1.2. Rising consumer demand for anti-aging products
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Government regulations on dosage
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTLE Analysis
  • 4.5. Nicotinamide Adenine Dinucleotide Industry trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Nicotinamide Adenine Dinucleotide Market, by Grade

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Nicotinamide Adenine Dinucleotide, by Grade, 2019-2032 (USD Million)
  • 5.3. Food Grade
    • 5.3.1. Global Nicotinamide Adenine Dinucleotide Market, by Food Grade, by Region, 2019-2032 (USD Million)
  • 5.4. Pharmaceutical Grade
    • 5.4.1. Global Nicotinamide Adenine Dinucleotide Market, by Pharmaceutical Grade, by Region, 2019-2032 (USD Million)
  • 5.5. Others
    • 5.5.1. Global Nicotinamide Adenine Dinucleotide Market, by Others, by Region, 2019-2032 (USD Million)

6. Global Nicotinamide Adenine Dinucleotide Market, by Application

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Nicotinamide Adenine Dinucleotide Market, by Application, 2019-2032 (USD Million)
  • 6.3. Dietary Supplements
    • 6.3.1. Global Nicotinamide Adenine Dinucleotide Market, by Dietary Supplements, by Region, 2019-2032 (USD Million)
  • 6.4. Pharmaceuticals
    • 6.4.1. Global Nicotinamide Adenine Dinucleotide Market, by Pharmaceuticals, by Region, 2019-2032 (USD Million)
  • 6.5. Anti-aging Products
    • 6.5.1. Global Nicotinamide Adenine Dinucleotide Market, by Anti-aging Products, by Region, 2019-2032 (USD Million)
  • 6.6. Others
    • 6.6.1. Global Nicotinamide Adenine Dinucleotide Market, by Others, by Region, 2019-2032 (USD Million)

7. Global Nicotinamide Adenine Dinucleotide Market, by Geography

  • 7.1. Key findings
  • 7.2. Introduction
    • 7.2.1. Nicotinamide Adenine Dinucleotide Market Assessment, By Geography, 2019-2032 (USD Million)
  • 7.3. Nicotinamide Adenine Dinucleotide Market - North America
    • 7.3.1. North America: Nicotinamide Adenine Dinucleotide Market, by Application, 2019-2032 (USD Million)
    • 7.3.2. North America: Nicotinamide Adenine Dinucleotide Market, by Grade, 2019-2032 (USD Million)
    • 7.3.3. Nicotinamide Adenine Dinucleotide Market - U.S.
      • 7.3.3.1. U.S.: Nicotinamide Adenine Dinucleotide Market, by Application, 2019-2032 (USD Million)
      • 7.3.3.2. U.S.: Nicotinamide Adenine Dinucleotide Market, by Grade, 2019-2032 (USD Million)
    • 7.3.4. Nicotinamide Adenine Dinucleotide Market - Canada
      • 7.3.4.1. Canada: Nicotinamide Adenine Dinucleotide Market, by Application, 2019-2032 (USD Million)
      • 7.3.4.2. Canada: Nicotinamide Adenine Dinucleotide Market, by Grade, 2019-2032 (USD Million)
  • 7.4. Nicotinamide Adenine Dinucleotide Market - Europe
    • 7.4.1. Europe: Nicotinamide Adenine Dinucleotide Market, by Application, 2019-2032 (USD Million)
    • 7.4.2. Europe: Nicotinamide Adenine Dinucleotide Market, by Grade, 2019-2032 (USD Million)
    • 7.4.3. Nicotinamide Adenine Dinucleotide Market - UK
      • 7.4.3.1. UK: Nicotinamide Adenine Dinucleotide Market, by Application, 2019-2032 (USD Million)
      • 7.4.3.2. UK: Nicotinamide Adenine Dinucleotide Market, by Grade, 2019-2032 (USD Million)
    • 7.4.4. Nicotinamide Adenine Dinucleotide Market - France
      • 7.4.4.1. France: Nicotinamide Adenine Dinucleotide Market, by Application, 2019-2032 (USD Million)
      • 7.4.4.2. France: Nicotinamide Adenine Dinucleotide Market, by Grade, 2019-2032 (USD Million)
    • 7.4.5. Nicotinamide Adenine Dinucleotide Market - Germany
      • 7.4.5.1. Germany: Nicotinamide Adenine Dinucleotide Market, by Application, 2019-2032 (USD Million)
      • 7.4.5.2. Germany: Nicotinamide Adenine Dinucleotide Market, by Grade, 2019-2032 (USD Million)
    • 7.4.6. Nicotinamide Adenine Dinucleotide Market - Italy
      • 7.4.6.1. Italy: Nicotinamide Adenine Dinucleotide Market, by Application, 2019-2032 (USD Million)
      • 7.4.6.2. Italy: Nicotinamide Adenine Dinucleotide Market, by Grade, 2019-2032 (USD Million)
    • 7.4.7. Nicotinamide Adenine Dinucleotide Market - Spain
      • 7.4.7.1. Spain: Nicotinamide Adenine Dinucleotide Market, by Application, 2019-2032 (USD Million)
      • 7.4.7.2. Spain: Nicotinamide Adenine Dinucleotide Market, by Grade, 2019-2032 (USD Million)
    • 7.4.8. Nicotinamide Adenine Dinucleotide Market - Netherlands
      • 7.4.8.1. Netherlands: Nicotinamide Adenine Dinucleotide Market, by Application, 2019-2032 (USD Million)
      • 7.4.8.2. Netherlands: Nicotinamide Adenine Dinucleotide Market, by Grade, 2019-2032 (USD Million)
    • 7.4.9. Nicotinamide Adenine Dinucleotide Market - Russia
      • 7.4.9.1. Russia: Nicotinamide Adenine Dinucleotide Market, by Application, 2019-2032 (USD Million)
      • 7.4.9.2. Russia: Nicotinamide Adenine Dinucleotide Market, by Grade, 2019-2032 (USD Million)
  • 7.5. Nicotinamide Adenine Dinucleotide Market - Asia Pacific
    • 7.5.1. Asia Pacific: Nicotinamide Adenine Dinucleotide Market, by Application, 2019-2032 (USD Million)
    • 7.5.2. Asia Pacific: Nicotinamide Adenine Dinucleotide Market, by Grade, 2019-2032 (USD Million)
    • 7.5.3. Nicotinamide Adenine Dinucleotide Market - China
      • 7.5.3.1. China: Nicotinamide Adenine Dinucleotide Market, by Application, 2019-2032 (USD Million)
      • 7.5.3.2. China: Nicotinamide Adenine Dinucleotide Market, by Grade, 2019-2032 (USD Million)
    • 7.5.4. Nicotinamide Adenine Dinucleotide Market - India
      • 7.5.4.1. India: Nicotinamide Adenine Dinucleotide Market, by Application, 2019-2032 (USD Million)
      • 7.5.4.2. India: Nicotinamide Adenine Dinucleotide Market, by Grade, 2019-2032 (USD Million)
    • 7.5.5. Nicotinamide Adenine Dinucleotide Market - Malaysia
      • 7.5.5.1. Malaysia: Nicotinamide Adenine Dinucleotide Market, by Application, 2019-2032 (USD Million)
      • 7.5.5.2. Malaysia: Nicotinamide Adenine Dinucleotide Market, by Grade, 2019-2032 (USD Million)
    • 7.5.6. Nicotinamide Adenine Dinucleotide Market - Japan
      • 7.5.6.1. Japan: Nicotinamide Adenine Dinucleotide Market, by Application, 2019-2032 (USD Million)
      • 7.5.6.2. Japan: Nicotinamide Adenine Dinucleotide Market, by Grade, 2019-2032 (USD Million)
    • 7.5.7. Nicotinamide Adenine Dinucleotide Market - Indonesia
      • 7.5.7.1. Indonesia: Nicotinamide Adenine Dinucleotide Market, by Application, 2019-2032 (USD Million)
      • 7.5.7.2. Indonesia: Nicotinamide Adenine Dinucleotide Market, by Grade, 2019-2032 (USD Million)
    • 7.5.8. Nicotinamide Adenine Dinucleotide Market - South Korea
      • 7.5.8.1. South Korea: Nicotinamide Adenine Dinucleotide Market, by Application, 2019-2032 (USD Million)
      • 7.5.8.2. South Korea: Nicotinamide Adenine Dinucleotide Market, by Grade, 2019-2032 (USD Million)
  • 7.6. Nicotinamide Adenine Dinucleotide Market - Middle East & Africa
    • 7.6.1. Middle East & Africa: Nicotinamide Adenine Dinucleotide Market, by Application, 2019-2032 (USD Million)
    • 7.6.2. Middle East & Africa: Nicotinamide Adenine Dinucleotide Market, by Grade, 2019-2032 (USD Million)
    • 7.6.3. Nicotinamide Adenine Dinucleotide Market - Saudi Arabia
      • 7.6.3.1. Saudi Arabia: Nicotinamide Adenine Dinucleotide Market, by Application, 2019-2032 (USD Million)
      • 7.6.3.2. Saudi Arabia: Nicotinamide Adenine Dinucleotide Market, by Grade, 2019-2032 (USD Million)
    • 7.6.4. Nicotinamide Adenine Dinucleotide Market - UAE
      • 7.6.4.1. UAE: Nicotinamide Adenine Dinucleotide Market, by Application, 2019-2032 (USD Million)
      • 7.6.4.2. UAE: Nicotinamide Adenine Dinucleotide Market, by Grade, 2019-2032 (USD Million)
    • 7.6.5. Nicotinamide Adenine Dinucleotide Market - Israel
      • 7.6.5.1. Israel: Nicotinamide Adenine Dinucleotide Market, by Application, 2019-2032 (USD Million)
      • 7.6.5.2. Israel: Nicotinamide Adenine Dinucleotide Market, by Grade, 2019-2032 (USD Million)
    • 7.6.6. Nicotinamide Adenine Dinucleotide Market - South Africa
      • 7.6.6.1. South Africa: Nicotinamide Adenine Dinucleotide Market, by Application, 2019-2032 (USD Million)
      • 7.6.6.2. South Africa: Nicotinamide Adenine Dinucleotide Market, by Grade, 2019-2032 (USD Million)
  • 7.7. Nicotinamide Adenine Dinucleotide Market - Latin America
    • 7.7.1. Latin America: Nicotinamide Adenine Dinucleotide Market, by Application, 2019-2032 (USD Million)
    • 7.7.2. Latin America: Nicotinamide Adenine Dinucleotide Market, by Grade, 2019-2032 (USD Million)
    • 7.7.3. Nicotinamide Adenine Dinucleotide Market - Mexico
      • 7.7.3.1. Mexico: Nicotinamide Adenine Dinucleotide Market, by Application, 2019-2032 (USD Million)
      • 7.7.3.2. Mexico: Nicotinamide Adenine Dinucleotide Market, by Grade, 2019-2032 (USD Million)
    • 7.7.4. Nicotinamide Adenine Dinucleotide Market - Brazil
      • 7.7.4.1. Brazil: Nicotinamide Adenine Dinucleotide Market, by Application, 2019-2032 (USD Million)
      • 7.7.4.2. Brazil: Nicotinamide Adenine Dinucleotide Market, by Grade, 2019-2032 (USD Million)
    • 7.7.5. Nicotinamide Adenine Dinucleotide Market - Argentina
      • 7.7.5.1. Argentina: Nicotinamide Adenine Dinucleotide Market, by Application, 2019-2032 (USD Million)
      • 7.7.5.2. Argentina: Nicotinamide Adenine Dinucleotide Market, by Grade, 2019-2032 (USD Million)

8. Competitive Landscape

  • 8.1. Expansion and Acquisition Analysis
    • 8.1.1. Expansion
    • 8.1.2. Acquisitions
  • 8.2. Partnerships/Collaborations/Agreements/Exhibitions

9. Company Profiles

  • 9.1. Bontac Bio-engineering
    • 9.1.1. Company Overview
    • 9.1.2. Financial Performance
    • 9.1.3. Product Benchmarking
    • 9.1.4. Recent Development
  • 9.2. Jubilant Life Sciences
    • 9.2.1. Company Overview
    • 9.2.2. Financial Performance
    • 9.2.3. Product Benchmarking
    • 9.2.4. Recent Development
  • 9.3. Koninklijke DSM
    • 9.3.1. Company Overview
    • 9.3.2. Financial Performance
    • 9.3.3. Product Benchmarking
    • 9.3.4. Recent Development
  • 9.4. Lasons India
    • 9.4.1. Company Overview
    • 9.4.2. Financial Performance
    • 9.4.3. Product Benchmarking
    • 9.4.4. Recent Development
  • 9.5. Resonance Specialties
    • 9.5.1. Company Overview
    • 9.5.2. Financial Performance
    • 9.5.3. Product Benchmarking
    • 9.5.4. Recent Development
  • 9.6. TCI Chemcials
    • 9.6.1. Company Overview
    • 9.6.2. Financial Performance
    • 9.6.3. Product Benchmarking
    • 9.6.4. Recent Development
  • 9.7. Vertellus Holdings
    • 9.7.1. Company Overview
    • 9.7.2. Financial Performance
    • 9.7.3. Product Benchmarking
    • 9.7.4. Recent Development
  • 9.8. Novo Nordisk
    • 9.8.1. Company Overview
    • 9.8.2. Financial Performance
    • 9.8.3. Product Benchmarking
    • 9.8.4. Recent Development
  • 9.9. Catalent
    • 9.9.1. Company Overview
    • 9.9.2. Financial Performance
    • 9.9.3. Product Benchmarking
    • 9.9.4. Recent Development
  • 9.10. Lonza Group
    • 9.10.1. Company Overview
    • 9.10.2. Financial Performance
    • 9.10.3. Product Benchmarking
    • 9.10.4. Recent Development
  • 9.11. Zhejiang Lanbo Biotechnology
    • 9.11.1. Company Overview
    • 9.11.2. Financial Performance
    • 9.11.3. Product Benchmarking
    • 9.11.4. Recent Development
  • 9.12. Otto Chemie
    • 9.12.1. Company Overview
    • 9.12.2. Financial Performance
    • 9.12.3. Product Benchmarking
    • 9.12.4. Recent Development
  • 9.13. Himedia Laboratories
    • 9.13.1. Company Overview
    • 9.13.2. Financial Performance
    • 9.13.3. Product Benchmarking
    • 9.13.4. Recent Development
  • 9.14. NutriScience Innovations
    • 9.14.1. Company Overview
    • 9.14.2. Financial Performance
    • 9.14.3. Product Benchmarking
    • 9.14.4. Recent Development

List of Tables

  • Table 1 Global Nicotinamide Adenine Dinucleotide Market, by Application, 2019-2032 (USD Million)
  • Table 2 Global Nicotinamide Adenine Dinucleotide Market, by Grade, 2019-2032 (USD Million)
  • Table 3 Nicotinamide Adenine Dinucleotide Market Assessment, By Geography, 2019-2032 (USD Million)
  • Table 4 North America: Nicotinamide Adenine Dinucleotide Market, by Application, 2019-2032 (USD Million)
  • Table 5 North America: Nicotinamide Adenine Dinucleotide Market, by Grade, 2019-2032 (USD Million)
  • Table 6 U.S.: Nicotinamide Adenine Dinucleotide Market, by Application, 2019-2032 (USD Million)
  • Table 7 U.S.: Nicotinamide Adenine Dinucleotide Market, by Grade, 2019-2032 (USD Million)
  • Table 8 Canada: Nicotinamide Adenine Dinucleotide Market, by Application, 2019-2032 (USD Million)
  • Table 9 Canada: Nicotinamide Adenine Dinucleotide Market, by Grade, 2019-2032 (USD Million)
  • Table 10 Europe: Nicotinamide Adenine Dinucleotide Market, by Application, 2019-2032 (USD Million)
  • Table 11 Europe: Nicotinamide Adenine Dinucleotide Market, by Grade, 2019-2032 (USD Million)
  • Table 12 UK: Nicotinamide Adenine Dinucleotide Market, by Application, 2019-2032 (USD Million)
  • Table 13 UK: Nicotinamide Adenine Dinucleotide Market, by Grade, 2019-2032 (USD Million)
  • Table 14 France: Nicotinamide Adenine Dinucleotide Market, by Application, 2019-2032 (USD Million)
  • Table 15 France: Nicotinamide Adenine Dinucleotide Market, by Grade, 2019-2032 (USD Million)
  • Table 16 Germany: Nicotinamide Adenine Dinucleotide Market, by Application, 2019-2032 (USD Million)
  • Table 17 Germany: Nicotinamide Adenine Dinucleotide Market, by Grade, 2019-2032 (USD Million)
  • Table 18 Italy: Nicotinamide Adenine Dinucleotide Market, by Application, 2019-2032 (USD Million)
  • Table 19 Italy: Nicotinamide Adenine Dinucleotide Market, by Grade, 2019-2032 (USD Million)
  • Table 20 Spain: Nicotinamide Adenine Dinucleotide Market, by Application, 2019-2032 (USD Million)
  • Table 21 Spain: Nicotinamide Adenine Dinucleotide Market, by Grade, 2019-2032 (USD Million)
  • Table 22 Netherlands: Nicotinamide Adenine Dinucleotide Market, by Application, 2019-2032 (USD Million)
  • Table 23 Netherlands: Nicotinamide Adenine Dinucleotide Market, by Grade, 2019-2032 (USD Million)
  • Table 24 Russia: Nicotinamide Adenine Dinucleotide Market, by Application, 2019-2032 (USD Million)
  • Table 25 Russia: Nicotinamide Adenine Dinucleotide Market, by Grade, 2019-2032 (USD Million)
  • Table 26 Asia Pacific: Nicotinamide Adenine Dinucleotide Market, by Application, 2019-2032 (USD Million)
  • Table 27 Asia Pacific: Nicotinamide Adenine Dinucleotide Market, by Grade, 2019-2032 (USD Million)
  • Table 28 China: Nicotinamide Adenine Dinucleotide Market, by Application, 2019-2032 (USD Million)
  • Table 29 China: Nicotinamide Adenine Dinucleotide Market, by Grade, 2019-2032 (USD Million)
  • Table 30 India: Nicotinamide Adenine Dinucleotide Market, by Application, 2019-2032 (USD Million)
  • Table 31 India: Nicotinamide Adenine Dinucleotide Market, by Grade, 2019-2032 (USD Million)
  • Table 32 Malaysia: Nicotinamide Adenine Dinucleotide Market, by Application, 2019-2032 (USD Million)
  • Table 33 Malaysia: Nicotinamide Adenine Dinucleotide Market, by Grade, 2019-2032 (USD Million)
  • Table 34 Japan: Nicotinamide Adenine Dinucleotide Market, by Application, 2019-2032 (USD Million)
  • Table 35 Japan: Nicotinamide Adenine Dinucleotide Market, by Grade, 2019-2032 (USD Million)
  • Table 36 Indonesia: Nicotinamide Adenine Dinucleotide Market, by Application, 2019-2032 (USD Million)
  • Table 37 Indonesia: Nicotinamide Adenine Dinucleotide Market, by Grade, 2019-2032 (USD Million)
  • Table 38 South Korea: Nicotinamide Adenine Dinucleotide Market, by Application, 2019-2032 (USD Million)
  • Table 39 South Korea: Nicotinamide Adenine Dinucleotide Market, by Grade, 2019-2032 (USD Million)
  • Table 40 Middle East & Africa: Nicotinamide Adenine Dinucleotide Market, by Application, 2019-2032 (USD Million)
  • Table 41 Middle East & Africa: Nicotinamide Adenine Dinucleotide Market, by Grade, 2019-2032 (USD Million)
  • Table 42 Saudi Arabia: Nicotinamide Adenine Dinucleotide Market, by Application, 2019-2032 (USD Million)
  • Table 43 Saudi Arabia: Nicotinamide Adenine Dinucleotide Market, by Grade, 2019-2032 (USD Million)
  • Table 44 UAE: Nicotinamide Adenine Dinucleotide Market, by Application, 2019-2032 (USD Million)
  • Table 45 UAE: Nicotinamide Adenine Dinucleotide Market, by Grade, 2019-2032 (USD Million)
  • Table 46 Israel: Nicotinamide Adenine Dinucleotide Market, by Application, 2019-2032 (USD Million)
  • Table 47 Israel: Nicotinamide Adenine Dinucleotide Market, by Grade, 2019-2032 (USD Million)
  • Table 48 South Africa: Nicotinamide Adenine Dinucleotide Market, by Application, 2019-2032 (USD Million)
  • Table 49 South Africa: Nicotinamide Adenine Dinucleotide Market, by Grade, 2019-2032 (USD Million)
  • Table 50 Latin America: Nicotinamide Adenine Dinucleotide Market, by Application, 2019-2032 (USD Million)
  • Table 51 Latin America: Nicotinamide Adenine Dinucleotide Market, by Grade, 2019-2032 (USD Million)
  • Table 52 Mexico: Nicotinamide Adenine Dinucleotide Market, by Application, 2019-2032 (USD Million)
  • Table 53 Mexico: Nicotinamide Adenine Dinucleotide Market, by Grade, 2019-2032 (USD Million)
  • Table 54 Brazil: Nicotinamide Adenine Dinucleotide Market, by Application, 2019-2032 (USD Million)
  • Table 55 Brazil: Nicotinamide Adenine Dinucleotide Market, by Grade, 2019-2032 (USD Million)
  • Table 56 Argentina: Nicotinamide Adenine Dinucleotide Market, by Application, 2019-2032 (USD Million)
  • Table 57 Argentina: Nicotinamide Adenine Dinucleotide Market, by Grade, 2019-2032 (USD Million)

List of Figures

Figure 1 Global Nicotinamide Adenine Dinucleotide Market, 2019-2032 (USD Million)

Figure 2 Integrated Ecosystem

Figure 3 Research Methodology: Top-Down & Bottom-Up Approach

Figure 4 Market by Geography

Figure 5 Porter's Five Forces

Figure 6 Market by Application

Figure 7 Global Nicotinamide Adenine Dinucleotide Market, by Application, 2022 & 2032 (USD Million)

Figure 8 Market by Grade

Figure 9 Global Nicotinamide Adenine Dinucleotide Market, by Grade, 2022 & 2032 (USD Million)

Figure 10 Nicotinamide Adenine Dinucleotide Market Assessment, By Geography, 2019-2032 (USD Million)

Figure 11 Strategic Analysis - Nicotinamide Adenine Dinucleotide Market